Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07560202

Portal Vein Thrombosis in Liver Cirrhosis: Clinical Characteristics, Radiological Patterns, and Predictors

Portal vein thrombosis (PVT) is a common complication in patients with liver cirrhosis and is associated with increased morbidity due to worsening portal hypertension and hepatic decompensation. The clinical presentation and radiological patterns of PVT vary widely, and the factors predicting its development remain incompletely understood.

This observational study will include adult patients (≥18 years) with established liver cirrhosis who are admitted to the Department of Gastroenterology and Tropical Medicine, Al-Rajhi Liver Hospital, Assiut University. Eligible participants will undergo routine screening for PVT using Doppler ultrasonography, with confirmation by contrast-enhanced computed tomography when indicated.

The study aims to evaluate the clinical characteristics, laboratory parameters, and radiological features of PVT. Cases of PVT will be classified according to extent (partial or complete) and anatomical location (main portal vein, right branch, left branch, or combined involvement). Clinical and laboratory data will be analyzed to identify potential predictors associated with the development and severity of PVT.

The findings of this study are expected to improve understanding of the risk factors and radiological patterns of PVT in cirrhotic patients, contributing to better risk stratification and clinical management.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Assiut University Hospital

Asyut, 71515, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients with liver cirrhosis

Exclusion criteria

  • Patients with non-hepatic hemostatic disorders, active bacterial sepsis, renal dysfunction, peripheral or hepatic venous thrombosis, recent splenectomy, liver transplantation, antiplatelet or anticoagulant therapy or contraceptive pills were excluded.

Treatment and study plan

Abdominal US, Doppler US and abdominal multi-slice computed tomography (MSCT) with contrast was performed

Diagnostic Test

to assess portal circulation, portosystemic collaterals, the presence of PVT, ascites and HCC.

Primary outcomes

  1. Prevalence of Portal Vein Thrombosis (PVT)

    Time frame: At baseline (during study enrollment period)

    Proportion of cirrhotic patients diagnosed with portal vein thrombosis based on Doppler ultrasonography with confirmation by contrast-enhanced CT when indicated.

  2. Predictors of Portal Vein Thrombosis

    Time frame: Baseline assessment

    Identification of clinical, laboratory, and radiological factors associated with the presence of PVT in cirrhotic patients

Secondary outcomes

  1. Radiological Pattern of PVT

    Time frame: At time of PVT diagnosis

    Distribution of portal vein thrombosis according to:

    Extent (partial vs complete) Anatomical location (main portal vein, right branch, left branch, or combined involvement)

  2. Association Between PVT Type and Clinical Parameters

    Time frame: At time of diagnosis

    Correlation between type of PVT (partial vs complete) and clinical/laboratory characteristics of patients.

Sponsors and collaborators

Lead sponsor

Elham Ahmed Hassan

Other

Registry information

Acronym: Thrombosis

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
May 1, 2026
Registry last updated
May 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.